OUR RESOURCES

All of Biotech and Money's content, in one place.

Community Partners

 

DEALS WATCH

Medius Deal Watch July 2017

The cheque books have been out in force in July, and payments were for subs...

Read More

Medius Deal Watch May Part II

Good morning, good morning

Read More

Medius Deal Watch May 2017 Part I

Following the scarcity of billion dollar headline deals in March, this mont...

Read More
VIEW MORE

EXECUTIVE AND EXPERT INSIGHTS

From Strength to Strength: Unpacking Clinigen's Route to Success

Putting patient care at the heart of its mission, Clinigen’s unique approac...

Read More

[Webinar Recording] The Current State of the M&A Landscape

Are you considering M&A transactions as a potential exit strategy, step to ...

Read More

[Webinar Recording] The Anatomy of a successful IPO

On the 27th June, we spoke to an expert panel to discuss the how, when, wha...

Read More

Will Horizon successfully navigate the path to profit?

Currently one of the most successful life science companies in the country,...

Read More

Management to investors: the communicative conundrum

We have published our annual investor perception survey, confirming or disp...

Read More

All in the Delivery - Interview with Simon Newman, CSO, Ryboquin

Biotech and Money recently talked to Simon Newman, CSO of Ryboquin, about t...

Read More

Interview with Daniel Oliver, CEO of Capital Cell

Daniel Oliver, CEO of Capital Cell, recently took the time to grant us an i...

Read More

Patenting problems specific to the biotech and healthcare sector

This is the fourth and final article in our series that aims to provide tip...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

Advice for investors

This blog is a summary of Chapter 6 of the Advanced Therapies Investment Re...

Read More

Understanding Biopharma Interest

This blog is a summary of Chapter 5 of the Advanced Therapies Investment Re...

Read More

Manufacturing Commercial Operations and Supply Chain

This blog is a summary of Chapter 4 of the Advanced Therapies Investment Re...

Read More

Building Value for Cell and Gene Therapies and Establishing Market Access Pathways

This blog is a summary of Chapter 3 of the Advanced Therapies Investment Re...

Read More

Understanding Cell & Gene Therapy Pipelines

This blog is a summary of Chapter 2 of the Advanced Therapies Investment Re...

Read More

Overview of Advanced Therapy Industry

This blog is a summary of Chapter 1 of the Advanced Therapies Investment Re...

Read More

Must-Know Finance Concepts for Life Sciences Valuations

By John Selig, Co-Founder and Managing Partner, Mavericks Capital When sell...

Read More

The Nuts & Bolts of Due Diligence in Biopharma Partnering

Based on a web panel discussion presented by ShareVault in association with...

Read More
View More

INVESTORVIEWS

Investorview - Investing in a Digital Future with Christoph Ruedig, Partner, Albion Capital

Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

Read More

Investorview – Precision Investing with Jay Goth, Managing Partner, Forentis Fund

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General Partner at ‎Julz Co

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More
VIEW MORE